tiprankstipranks
Trending News
More News >
Niagen Bioscience (NAGE)
NASDAQ:NAGE
US Market

Niagen Bioscience (NAGE) Income Statement

Compare
604 Followers

Niagen Bioscience Income Statement

Last quarter (Q3 2025), Niagen Bioscience's total revenue was $33.99M, an increase of 32.86% from the same quarter last year. In Q3, Niagen Bioscience's net income was $4.58M. See Niagen Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 99.60M$ 83.57M$ 72.05M$ 67.45M$ 59.26M
Gross Profit
$ 61.59M$ 50.78M$ 42.80M$ 41.49M$ 35.27M
Operating Expenses
$ 53.86M$ 56.38M$ 61.42M$ 68.56M$ 55.13M
Depreciation and Amortization
$ 1.48M$ 1.71M$ 1.88M$ 1.63M$ 1.51M
EBITDA
$ 9.21M$ -3.89M$ -16.74M$ -25.45M$ -18.34M
Operating Income
$ 7.73M$ -5.60M$ -18.63M$ -27.07M$ -19.85M
Other Income/Expenses
$ 1.13M$ 661.00K$ 2.09M$ -55.00K$ -71.00K
Pretax Income
$ 8.86M$ -4.94M$ -16.54M$ -27.13M$ -19.93M
Net Income
$ 8.55M$ -4.94M$ -16.54M$ -27.13M$ -19.93M
Per Share Metrics
Basic EPS
$ 0.10$ -0.07$ -0.24$ -0.40$ -0.33
Diluted EPS
$ 0.11$ -0.07$ -0.24$ -0.40$ -0.33
Weighted Average Shares Outstanding
85.42M 70.54M 68.92M 67.19M 61.07M
Weighted Average Shares Outstanding (Diluted)
79.72M 74.98M 69.73M 67.19M 61.07M
Currency in USD

Niagen Bioscience Earnings and Revenue History